SKK
N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide
Find entries where: SKK
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide |
Synonyms | Anagliptin |
Identifiers | N-[2-[[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxidanylidene-ethyl]amino]-2-methyl-propyl]-2-methyl-pyrazolo[1,5-a]pyrimidine-6-carboxamide |
Formula | C19 H25 N7 O2 |
Molecular Weight | 383.448 |
Type | NON-POLYMER |
Isomeric SMILES | Cc1cc2ncc(cn2n1)C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N |
InChI | InChI=1S/C19H25N7O2/c1-13-7-16-21-9-14(11-26(16)24-13)18(28)22-12-19(2,3)23-10-17(27)25-6-4-5-15(25)8-20/h7,9,11,15,23H,4-6,10,12H2,1-3H3,(H,22,28)/t15-/m0/s1 |
InChIKey | LDXYBEHACFJIEL-HNNXBMFYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 53 |
Chiral Atom Count | 1 |
Bond Count | 55 |
Aromatic Bond Count | 10 |
Drug Info: DrugBank
DrugBank ID | DB12417 |
---|---|
Name | Anagliptin |
Groups | investigational |
Description | Anagliptin is under investigation for the treatment of LDL Cholesterol, Coronary Disease, Diabetes Mellitus, Glycosylated Hemoglobin, and Dipeptidyl-Peptidase 4 Inhibitors. |
Synonyms | Anagliptin |
Categories |
|
CAS number | 739366-20-2 |
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 44513473 |
ChEMBL | CHEMBL1929396 |
ChEBI | CHEBI:136043 |
CCDC/CSD | KAKGUB |